Template:Melanocortin receptor modulators: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
m 1 revision imported |
||
| (One intermediate revision by one other user not shown) | |||
| Line 39: | Line 39: | ||
* [[Tricosactide]] | * [[Tricosactide]] | ||
* [[Tridecactide]] | * [[Tridecactide]] | ||
* '''Antagonists:''' [[Atumelnant|Atumelnant (CRN04894)]] | |||
| group3 = [[Melanocortin 3 receptor|MC<sub>3</sub>]] | | group3 = [[Melanocortin 3 receptor|MC<sub>3</sub>]] | ||
| Line 53: | Line 55: | ||
* [[Agouti signalling peptide|ASIP]] | * [[Agouti signalling peptide|ASIP]] | ||
* [[HS-014]] | * [[HS-014]] | ||
* [[Mifomelatide|Mifomelatide (TCMCB07)]] | |||
* [[ML-00253764]] | * [[ML-00253764]] | ||
* [[PG-106]] | * [[PG-106]] | ||
| Line 65: | Line 68: | ||
* [[AZD2820]] | * [[AZD2820]] | ||
* [[BIM-22493]] | * [[BIM-22493]] | ||
* [[Bivamelagon|Bivamelagon (LB54640)]] | |||
* [[Bremelanotide]] | * [[Bremelanotide]] | ||
* [[LY-2112688]] | * [[LY-2112688]] | ||
| Line 132: | Line 136: | ||
* [[N-Terminal peptide of proopiomelanocortin|N-POMC (NPP, pro-γ-MSH)]] | * [[N-Terminal peptide of proopiomelanocortin|N-POMC (NPP, pro-γ-MSH)]] | ||
* [[Proopiomelanocortin|Proopiomelanocortin (POMC)]] | * [[Proopiomelanocortin|Proopiomelanocortin (POMC)]] | ||
}}<noinclude> | }}<noinclude> | ||
| Line 140: | Line 141: | ||
[[Category:Drug templates by receptor, channel, or pump]] | [[Category:Drug templates by receptor, channel, or pump]] | ||
</noinclude> | </noinclude> | ||
Latest revision as of 19:41, 8 March 2025
| Melanocortin receptor modulators | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
